Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma. 2015

Minyan Wei, and Xiucai Guo, and Liuxiao Tu, and Qi Zou, and Qi Li, and Chenyi Tang, and Bao Chen, and Yuehong Xu, and Chuanbin Wu
Department of Pharmaceutics, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, People's Republic of China ; Department of Pharmaceutics, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, People's Republic of China.

Lactoferrin (Lf) is a potential-targeting ligand for hepatocellular carcinoma (HCC) cells because of its specific binding with asialoglycoprotein receptor (ASGPR). In this present work, a doxorubicin (DOX)-loaded, Lf-modified, polyethylene glycol (PEG)ylated liposome (Lf-PLS) system was developed, and its targeting effect and antitumor efficacy to HCC was also explored. The DOX-loaded Lf-PLS system had spherical or oval vesicles, with mean particle size approximately 100 nm, and had an encapsulation efficiency of 97%. The confocal microscopy and flow cytometry indicated that the cellular uptake of Lf-PLS was significantly higher than that of PEGylated liposome (PLS) in ASGPR-positive cells (P<0.05) but not in ASGPR-negative cells (P>0.05). Cytotoxicity assay by MTT demonstrated that DOX-loaded Lf-PLS showed significantly stronger antiproliferative effects on ASGPR-positive HCC cells than did PLS without the Lf modification (P<0.05). The in vivo antitumor studies on male BALB/c nude mice bearing HepG2 xenografts demonstrated that DOX-loaded Lf-PLS had significantly stronger antitumor efficacy compared with PLS (P<0.05) and free DOX (P<0.05). All these results demonstrated that a DOX-loaded Lf-PLS might have great potential application for HCC-targeting therapy.

UI MeSH Term Description Entries
D007781 Lactoferrin An iron-binding protein that was originally characterized as a milk protein. It is widely distributed in secretory fluids and is found in the neutrophilic granules of LEUKOCYTES. The N-terminal part of lactoferrin possesses a serine protease which functions to inactivate the TYPE III SECRETION SYSTEM used by bacteria to export virulence proteins for host cell invasion. Lactotransferrin
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell

Related Publications

Minyan Wei, and Xiucai Guo, and Liuxiao Tu, and Qi Zou, and Qi Li, and Chenyi Tang, and Bao Chen, and Yuehong Xu, and Chuanbin Wu
June 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Minyan Wei, and Xiucai Guo, and Liuxiao Tu, and Qi Zou, and Qi Li, and Chenyi Tang, and Bao Chen, and Yuehong Xu, and Chuanbin Wu
June 2018, Journal of biomedical nanotechnology,
Minyan Wei, and Xiucai Guo, and Liuxiao Tu, and Qi Zou, and Qi Li, and Chenyi Tang, and Bao Chen, and Yuehong Xu, and Chuanbin Wu
September 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Minyan Wei, and Xiucai Guo, and Liuxiao Tu, and Qi Zou, and Qi Li, and Chenyi Tang, and Bao Chen, and Yuehong Xu, and Chuanbin Wu
October 2015, Yao xue xue bao = Acta pharmaceutica Sinica,
Minyan Wei, and Xiucai Guo, and Liuxiao Tu, and Qi Zou, and Qi Li, and Chenyi Tang, and Bao Chen, and Yuehong Xu, and Chuanbin Wu
January 2012, International journal of nanomedicine,
Minyan Wei, and Xiucai Guo, and Liuxiao Tu, and Qi Zou, and Qi Li, and Chenyi Tang, and Bao Chen, and Yuehong Xu, and Chuanbin Wu
March 2021, Molecular pharmaceutics,
Minyan Wei, and Xiucai Guo, and Liuxiao Tu, and Qi Zou, and Qi Li, and Chenyi Tang, and Bao Chen, and Yuehong Xu, and Chuanbin Wu
November 2011, Journal of controlled release : official journal of the Controlled Release Society,
Minyan Wei, and Xiucai Guo, and Liuxiao Tu, and Qi Zou, and Qi Li, and Chenyi Tang, and Bao Chen, and Yuehong Xu, and Chuanbin Wu
June 2019, Colloids and surfaces. B, Biointerfaces,
Minyan Wei, and Xiucai Guo, and Liuxiao Tu, and Qi Zou, and Qi Li, and Chenyi Tang, and Bao Chen, and Yuehong Xu, and Chuanbin Wu
July 2016, Nanomaterials (Basel, Switzerland),
Minyan Wei, and Xiucai Guo, and Liuxiao Tu, and Qi Zou, and Qi Li, and Chenyi Tang, and Bao Chen, and Yuehong Xu, and Chuanbin Wu
November 2014, Journal of biomaterials applications,
Copied contents to your clipboard!